Antibiotic consumption and chlamydia prevalence in international studies

Sexual Health

Volumn 3, Issue 4, 2006, Pages 221-224

  Ginige, Samitha ^a,b   Chen, Marcus Y ^a,c   Hocking, Jane S ^c   Read, Tim R H ^a   Fairley, Christopher K ^a,c  

^a MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^b Rev Baddegama Wimalawansa Thero Mawatha   (Sri Lanka)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; NUCLEIC ACID; TETRACYCLINE;

ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; ECOSYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; PREVALENCE; SEXUALLY TRANSMITTED DISEASES, BACTERIAL;

EID: 33751163747     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH06013     Document Type: Article

References (25)

1. Brunham RC, Pourbohloul B, Mak S et al. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005; 192: 1836-44. doi: 10.1086/497341
2. Scholes D, Stergachis A, Heidrich FE et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-6. doi: 10.1056/NEJM199605233342103
3. Schachter J. Biology of Chlamydia trachomatis. In: Holmes K, Mårdh P, Sparling P et al., editors. Sexually transmitted diseases, 3rd ed. New York: McGraw-Hill; 1999.
4. Goossens H, Ferech M, Stichele RV et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
5. European surveillance of antimicrobial consumption 2002: results of ESAC project. Available online at: www.esac.ua.ac.be/main.aspx?c=*ESAC2&n= 21641 [verified November 2006].
6. Australian statistics on medicines 2001-2002. Canberra: Australian Government, Department of Health and Ageing; 2004.
7. Patrick DM, Marra F, Hutchinson J et al. Per capita antibiotic consumption: How does a North American jurisdiction compare with Europe? Clin Infect Dis 2004; 39: 11-7. doi: 10.1086/420825
8. Nyari T, Woodward M, Kovacs L. Should all sexually active young women in Hungary be screened for Chlamydia trachomatis? Eur J Obstet Gynecol Reprod Biol 2003; 106: 55-9. doi: 10.1016/S0301-2115(02)00222-1
9. Andersen B, Olesen F, Moller JK et al. Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: A randomized, controlled trial. J Infect Dis 2002; 185: 252-8. doi: 10.1086/338268
10. Macleod J, Salisbury C, Low N et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 2005; 330: 940-2.
11. Sylvan SPE, Krogh GV, Tiveljung A et al. Screening and genotyping of genital Chlamydia trachomatis in urine specimens from male and female clients of youth-health centers in Stockholm county. Sex Transm Dis 2002; 29: 379-86.
12. Verhoeven V, Avonts D, Meheus A et al. Chlamydia infection: an accurate model for opportunistic screening in general practice. Sex Transm Infect 2003; 79: 313-7. doi: 10.1136/sti.79.4.313
13. Brito de Sa A, Gomes PJ, Viegas S et al. Genital infection by Chlamydia trachomatis in Lisbon: prevalence and risk markers. Fam Pract 2002; 19: 362-4. doi: 10.1093/fampra/19.4.362
14. Paukku M, Kilpikari R, Puolakkainen M et al. Criteria for selective screening for Chlamydia trachomatis. Sex Transm Dis 2003; 30: 120-3.
15. Bakken IJ, Brat H, Skjeldestad FE et al. Detection of Chlamydia trachomatis in urine, vulval and cervical swabs. Tidsskr Nor Laegeforen 2005; 125: 1629-30.
16. Klavs I, Rodrigues LC, Wellings K et al. Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control. Sex Transm Infect 2004; 80: 121-3. doi: 10.1136/sti.2003.005900
17. Hocking J, Willis J, Tabrizi S et al. Chlamydia risk factor and prevalence survey of young women aged 18 to 35 years living in Victoria. Proceedings ISSTDR Conference; 2005 July; Amsterdam, The Netherlands.
18. Orfila J, Mention JE, Sueur JM et al. Systematic screening for Chlamydia trachomatis with the molecular biological AMP-CT test in urine samples from young women. J Gynecol Obstet Biol Reprod (Paris) 2002; 31: 555-7.
19. van Bergen J, Gotz HM, Richardus JH et al. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanization and suggests targeted screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 2005; 81: 17-23. doi: 10.1136/sti.2004.010173
20. Diez Roux AV, Schwartz S, Susser E. Ecological variables, ecological studies, and multilevel studies in public health research. In: Oxford textbook of public health, 4th ed. Oxford: Oxford University Press; 2002.
21. Turner CF, Rogers SM, Miller HG et al. Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA 2002; 287: 726-33. doi: 10.1001/jama.287.6.726
22. Fairley CK, Hocking J, Gunn J, Chen MY. No barriers to chlamydia testing in sexually active young women. Med J Aust 2005; 183: 548-9.
23. Low N, Egger M. What should we do about screening for genital chlamydia? Int J Epidemiol 2002; 31: 891-3. doi: 10.1093/ije/31.5.891
24. Miller WC. Screening for chlamydial infection: are we doing enough? Lancet 2005; 365: 456-8.
25. Turnidge J. Antibiotic use or misuse? MJA 1997; 167: 116-7.